At the National Athletic Trainers Association meeting, the inventors of sam® showcase the clinically validated, FDA-cleared device that revolutionizes recovery from soft-tissue injuries for athletes and active people, with endorsements from physicians, professional athletes, and military veterans.
PHILADELPHIA, PA / ACCESS Newswire / July 2, 2026 / ZetrOZ Systems unveiled sam® 3.0, the new evolution of its award-winning Sustained Acoustic Medicine wearable ultrasound technology, at the annual meeting of the National Athletic Trainers Association (NATA) on June 29-July 2.
The sam® device has been clinically validated in 40 studies to accelerate healing and reduce pain in soft-tissue injuries common to amateur and professional athletes, making the NATA conference an ideal setting for the national launch of sam® 3.0.
The Connecticut-based ZetrOZ Systems team presented the new device and met with athletic trainers to collect patient feedback for use in developing educational material and possible future refinements to the sam® technology, which is defined and protected by 48 U.S. and global patents.
"sam® 3.0 represents our continued commitment to making clinically proven wearable ultrasound therapy easier, more effective, and more accessible for athletes," said Dr. George K. Lewis for ZetrOZ Systems. "The overwhelmingly positive feedback at NATA 2026 from physicians, athletes, researchers, and longtime users reinforces that sam® 3.0 is the next step forward in healing technology."
